Frontlight ResearchEarly access
Neuromyelitis optica (NMOSD) trials in Israel
1 trial · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peoplePhase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases
- Where
- Jerusalem
- Age
- 18 years to 80 years
- People
- 120
- Run by
- Polina Stepensky
See details and how to joinNCT07085676